115 related articles for article (PubMed ID: 3292414)
1. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity.
Kleinert HD; Martin D; Chekal MA; Kadam J; Luly JR; Plattner JJ; Perun TJ; Luther RR
Hypertension; 1988 Jun; 11(6 Pt 2):613-9. PubMed ID: 3292414
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
Kleinert HD; Martin D; Chekal M; Young G; Rosenberg S; Plattner JJ; Perun TJ
J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin inhibition in the conscious primate Macaca fascicularis.
Hui KY; Knight DR; Nussberger J; Hartley LH; Vatner SF; Haber E
Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962
[TBL] [Abstract][Full Text] [Related]
5. Renal hemodynamic and excretory responses to renin inhibition induced by A-64662.
Verburg KM; Kleinert HD; Chekal MA; Kadam JR; Young GA
J Pharmacol Exp Ther; 1990 Feb; 252(2):449-55. PubMed ID: 2179529
[TBL] [Abstract][Full Text] [Related]
6. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
[TBL] [Abstract][Full Text] [Related]
7. An orally active inhibitor of renin.
Pals DT; Thaisrivongs S; Lawson JA; Kati WM; Turner SR; DeGraaf GL; Harris DW; Johnson GA
Hypertension; 1986 Dec; 8(12):1105-12. PubMed ID: 3539793
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive effects of the renin inhibitor (RI-78) and the converting enzyme inhibitor (teprotide) in conscious monkeys.
Takaori K; Hartley LH; Burton J
Clin Exp Hypertens A; 1987; 9(2-3):387-90. PubMed ID: 3038400
[TBL] [Abstract][Full Text] [Related]
9. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
Schaffer LW; Schorn TW; Winquist RJ; Strouse JF; Payne L; Chakravarty PK; de Laszlo SE; tenBroeke J; Veber DF; Greenlee WJ
J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
[TBL] [Abstract][Full Text] [Related]
10. Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerations.
Palmer RK; Rapundalo ST; Batley BL; Barnes AE; Singh S; Ryan MJ; Taylor DG
Clin Exp Hypertens; 1993 Jul; 15(4):663-81. PubMed ID: 8374609
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.
De Claviere M; Cazaubon C; Lacour C; Nisato D; Gagnol JP; Evin G; Corvol P
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S58-61. PubMed ID: 2412015
[TBL] [Abstract][Full Text] [Related]
12. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.
Lacour C; Cazaubon C; Roccon A; Segondy D; Wagnon J; Nisato D
J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
Lacour C; Roccon A; Cazaubon C; Segondy D; Nisato D
J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma renin during renin inhibition. Studies with a novel immunoassay.
Hofbauer KG; Wood JM; Gulati N; Heusser C; Ménard J
Hypertension; 1985; 7(3 Pt 2):I61-5. PubMed ID: 2987126
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogs.
Wessale JL; Calzadilla SV; Boyd SA; Baker WR; Stein HH; Kovar PJ; Barlow J; Klinghofer V; Mantei R; Kleinert HD
J Cardiovasc Pharmacol; 1993 Oct; 22(4):644-52. PubMed ID: 7505369
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of novel imidazole alcohol inhibitors of primate renin.
DeForrest JM; Waldron TL; Oehl RS; Scalese RJ; Free CA; Weller HN; Ryono DE
J Hypertens Suppl; 1989 Apr; 7(2):S15-9. PubMed ID: 2666607
[TBL] [Abstract][Full Text] [Related]
17. KRI-1314: an orally effective inhibitor of human renin.
Etoh Y; Miyazaki M; Saitoh H; Toda N
Jpn J Pharmacol; 1993 Sep; 63(1):109-19. PubMed ID: 8271523
[TBL] [Abstract][Full Text] [Related]
18. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
Geyskes GG; Boer P; Vos J; Leenen FH; Mees EJ
Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J
Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
[TBL] [Abstract][Full Text] [Related]
20. [Hypotensive action of human renin inhibitor KRI-1314 in the common marmoset].
Saitoh H; Etoh Y; Murakami M; Kubota T; Miyazaki M
Nihon Yakurigaku Zasshi; 1994 Apr; 103(4):161-73. PubMed ID: 8175079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
